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Abstract 
Clinical transcranial Doppler assessment of cerebral vasomotor reactivity (CVMR) 
uses linear regression of cerebral blood flow velocity (CBFV) vs. end-tidal CO2 
(PETCO2) under steady-state conditions. However, the cerebral blood flow (CBF)-
PETCO2 relationship is nonlinear, even for moderate changes in CO2. Moreover, 
CBF is increased by increases in arterial blood pressure (ABP) during 
hypercapnia. We used a modified rebreathing protocol to estimate CVMR during 
transient breath-by-breath changes in CBFV and PETCO2. Ten healthy subjects (6 
men) performed 15 s of hyperventilation followed by 5 min of rebreathing, with 
supplemental O2 to maintain arterial oxygen saturation constant. To minimize 
effects of changes in ABP on CVMR estimation, cerebrovascular conductance 
index (CVCi) was calculated. CBFV-PETCO2 and CVCi-PETCO2 relationships were 
quantified by both linear and nonlinear logistic regression. In three subjects, 
muscle sympathetic nerve activity was recorded. From hyperventilation to 
rebreathing, robust changes occurred in PETCO2 (20–61 Torr), CBFV (-44 to 
+104% of baseline), CVCi (-39 to +64%), and ABP (-19 to +23%) (all P < 0.01). 
Muscle sympathetic nerve activity increased by 446% during hypercapnia. The 
linear regression slope of CVCi vs. PETCO2 was less steep than that of CBFV (3 
vs. 5%/Torr; P = 0.01). Logistic regression of CBF-PETCO2 (r2 = 0.97) and CVCi-
PETCO2 (r2 = 0.93) was superior to linear regression (r2 = 0.91, r2 = 0.85; P = 0.01). 
CVMR was maximal (6–8%/Torr) for PETCO2 of 40–50 Torr. In conclusion, CBFV 
and CVCi responses to transient changes in PETCO2 can be described by a 
nonlinear logistic function, indicating that CVMR estimation varies within the range 
from hypocapnia to hypercapnia. Furthermore, quantification of the CVCi-PETCO2 
relationship may minimize the effects of changes in ABP on the estimation of 
CVMR. The method developed provides insight into CVMR under transient breath 
by-breath changes in CO2.  
 
Introduction 
The prominent cerebral blood flow (CBF) responses to changes in arterial CO2 are 
a unique characteristic of the cerebral vasculature.1,2 These responses have been 
quantified to reflect cerebral vasomotor reactivity (CVMR)3, even though the 
underlying mechanisms are still not completely understood.4 With the advent of 
transcranial Doppler (TCD) for measurement of CBF velocity (CBFV) with high 
temporal resolution, the Doppler-CO2 test of CVMR has become a widely adopted 
method in research and clinical practice practice. Research exploring the 
physiological characteristics of CVMR has demonstrated that the relationship 
between arterial CO2 and CBF is nonlinear and that this relationship is affected by 
CO2-induced changes in arterial blood pressure (ABP).3,5-12 In addition, the control 
mechanisms that govern the responses of CBF and ABP to CO2 have dynamic 
properties.5,9,11 Despite these complexities associated with the CBF-CO2 
relationship, measurement of CVMR has been widely applied in clinical practice to 
evaluate cerebral vascular function, e.g., in patients with carotid artery stenosis or 
hypertension.3,13-15 These clinical studies have quantified CVMR using linear 
regression of steady-state responses of CBF to changes in CO2, without 
incorporation of the effects of ABP. The likely reason for this simplicity is that well-
controlled experiments and complex modeling methods may not be practical for 
clinical use.9,16 In this regard, development of a new method that is clinically 
applicable and may assess CVMR reliably under conditions of breath-by-breath 
changes in end-tidal CO2 (PETCO2) is warranted.  
 We used a modified rebreathing protocol, consisting of a period of voluntary 
hyperventilation, followed by rebreathing, to obtain a wide range of changes in 
PETCO2 to assess CVMR under breath-by-breath conditions.17 We hypothesized 
that the CBF-PETCO2 relationship is nonlinear during transient changes in PETCO2. 
In addition, we speculated that measurement of cerebrovascular conductance 
index (CVCi) during this process may reveal direct effects of changes in ABP on 
CBF, leading to a more precise estimation of CVMR based on the CVCi-PETCO2 
relationship. Finally, to explore the underlying mechanisms of increases in ABP 
during hypercapnia, we recorded muscle sympathetic nerve activity (MSNA) in 
three subjects in this study. 
 
Methods 
Ten healthy subjects (4 women) with a mean age of 37 yr (SD 8), height 177 cm 
(SD 10), and weight 84 kg (SD 18) voluntarily participated in the study. 
Participants were nonsmokers, were not on any medication, and were 
normotensive. Participants were free of known cardiovascular, cerebrovascular, or 
respiratory disease. Each subject was informed of the experimental procedures 
and signed a consent form, approved by the Institutional Review Boards of the 
University of Texas Southwestern Medical Center and Presbyterian Hospital of 
Dallas.  
 
Protocol. Each participant visited the laboratory twice, 3–4 wk apart (in three 
participants, the time interval was 3–4 mo). All experiments took place in a quiet 
laboratory with a room temperature or alcoholic beverages at least 12 h before the 
tests. The study was conducted with the subjects in the supine position. Therefore, 
assessment of CVMR would be comparable with those obtained with other 
imaging technology.16 Participants wore a nose clip and breathed through a 
mouthpiece with a Y-valve, with one end connected to a 5-liter rubber bag and the 
other end open to room air. This system was held in place by an adjustable cable, 
rendering it practically weightless to avoid any discomfort for the subject. After at 
least 20 min of stabilization, 2 min of baseline data during spontaneous breathing 
were recorded on room air. A modified Read rebreathing protocol was used.17,18,19 
The procedure contains a period of voluntary hyperventilation preceding 
rebreathing to obtain a wider range of CO2 changes. Specifically, a short period of 
15 s of hyperventilation with a duty cycle of 1 s and maximal voluntary deep 
breaths were used. This short period of hyperventilation reduced PETCO2 to ~20 
Torr but did not cause respiratory muscle fatigue or central hypoxia possibly 
associated with a prolonged hyperventilation as employed in the other rebreathing 
methods.18,19 At the end of a deep inspiration, the respiratory valve was switched 
to the empty bag and then the bag was filled with the subjects’ own breathing gas 
during expiration (with a PETCO2 of ~20 Torr, comparable to a gas mixture with 
2.6% CO2). Rebreathing was continued for 5 min, before returning to room air for 
recovery (4 min). During rebreathing, a small amount of oxygen was bled into the 
rebreathing bag at the subject’s basal metabolic rate (estimated using the Harris-
Benedict formula) to maintain arterial oxygen saturation (SaO2) constant.20 
 
Instrumentation and data acquisition. The middle cerebral artery (MCA) was 
insonated with a 2-MHz pulsed Doppler ultrasound system (Multi-Dope X2; DWL). 
The probe was securely attached to the cranium by a mold that was cast 
individually to fit the facial bone structure.21 In this way, the exact position and 
angle of the probe were preserved during the repeat tests. 
 Throughout the test, ABP was monitored noninvasively using a Finapres 
(Ohmeda 2300) and was corroborated by concurrent electrosphygmomanometry 
(SunTech Medical) with measurements at intervals of 1 min. PETCO2 was recorded 
using a capnograph (POET TE; Criticare Systems), SaO2 was measured using a 
pulse oximeter (Biox 3700; Ohmeda), and heart rate (HR) was monitored with a 
three-lead ECG connected to a cardiotachometer (Quinton Instruments). 
 MSNA was recorded in three participants. MSNA signals were obtained by the 
microneurographic technique.22 Sympathetic bursts were identified by a computer 
program and then were confirmed by an experienced microneurographer. The 
number of bursts per minute (burst frequency) and the sum of the integrated burst 
area per minute (total activity) were used as quantitative indexes. Specifically, total 
activity was normalized to the baseline value (set at 100%) to reflect changes in 
sympathetic activity during CO2 stimuli.  
 
Data analysis. Off-line data analysis was performed with commercially available 
software (Acknowledge; BIOPAC Systems). For hyperventilation, the time delay 
between the onset of hyperventilation and the onset of changes in CBFV and ABP 
was measured. Similarly, at the end of rebreathing, the time delays for recovery 
between PETCO2, CBFV, and ABP were measured. Values for CBFV, ABP, and 
PETCO2 at the last minute of recovery were compared with their pretest baseline. 
Breathing cycles were identified from the respiratory CO2 signal. For each cycle, 
the corresponding value for PETCO2 and mean values for CBFV, ABP, and HR 
were measured. Averaging the number of cardiac cycles (usually 6) has been 
applied previously in an attempt to reduce respiratory hemodynamic variability.23 
We preferred to identify each respiratory cycle24 to derive the breath-to-breath 
CBFV-PETCO2 relationship. During the short breathing cycles in hyperventilation, 
an average of data from two cycles was used. Because CBFV is affected directly 
by changes in ABP2,5,6,10, CVCi was calculated by dividing mean CBFV by mean 
ABP within each breath cycle to reveal intrinsic vascular responses to changes in 
CO2. Furthermore, percent changes from baseline CBFV and CVCi values were 
calculated for data analysis. Data ranging from the nadir of PETCO2 during 
hyperventilation to the end of rebreathing were utilized for curve fitting to quantify 
the CBFV-PETCO2 and CVCi-PETCO2 relationship. 
 A four-parameter logistic function was used for curve fitting25: 
f(x) = y0 - 
a 
(1) 
1+e[bx (x-x0)] 
 
where f(x) represents percent changes in CBFV or CVCi (x representing PETCO2). 
The model parameter a represents the range of change in CBFV or CVCi, y0 is the 
maximum value of CBFV or CVCi during hypercapnia, x0 is the level of PETCO2 
where the first-order derivative of the logistic function (the slope of the curve) is 
maximal, and b is related to the overall curvilinear properties of the sigmoidal 
curve (Fig. 1). Nonlinear curve fitting was performed with a Marquardt-Levenberg 
algorithm for model parameter identification (SigmaPlot 8.02; SPSS). The 
selection of this model was based on the feature of curvilinear distribution of 
breath-by-breath changes in CBFV or CVCi vs. PETCO2 (Fig. 2) and the fact that 
model parameters of the selected logistic function have clear physiological 
implications, as shown in Fig. 1.25 
 The first-order derivative of the logistic function was calculated with the following 
equation: 
f’(x) =  
a x b x e[bx (x-x0)] 
(2) 
{1+e[bx (x-x0)]}2 
 
This derivative function yields the specific CO2 sensitivity (or CVMR) for each 
PETCO2. At x = x0, CVMR becomes maximal (CVMRmax), and Eq. 2 becomes (a x 
b)/4. Of note, CVMRmax derived from the CBFV-PETCO2 relationship was denoted 
as CBFVCVMRmax and CVMRmax derived from the CVCi-PETCO2 relationship 
was denoted as CVCi-CVMRmax. 
 
 
 
Fig. 1. Schematic representation of a logistic function with 4 parameters to be identified. a, Total 
range of changes in cerebrovascular conductance index (CVCi) or cerebral blood flow velocity (CBFV); y0, 
maximum value; x0, level of end-tidal CO2 (PETCO2) that exhibits highest CO2 sensitivity; b, curvilinear 
properties of the sigmoidal curve. 
 
For comparison, linear regressions of changes in CBFV and CVCi vs. PETCO2 
were conducted for the entire range of changes in PETCO2, from the nadir of 
hyperventilation to the end of rebreathing. The slopes of these linear regressions 
were defined as CBFV-CVMR0 and CVCi-CVMR0, respectively. In addition, to 
complement the assessment of CVMRmax with the derivative method, CVMR was 
estimated by the linear regressions in the steep part of the sigmoidal curves, and 
these results were defined as CBFV-CVMR1 and CVCi-CVMR1, respectively. 
 
Statistics. The results of curve fitting were examined by the correlation coefficients 
(r2) and by model residual analysis of individual data (SigmaPlot 8.02; SPSS). 
Thus individual data for r2 as well as mean sum of squares were available for both 
linear and logistic curve fits, allowing comparisons of both methods on using 
paired t-tests (SigmaStat 3.11; Systat Software). Comparisons of cerebral 
hemodynamics at baseline, during hyperventilation, and during rebreathing were 
made with one-way repeated-measures ANOVA. Comparisons between the 
estimates of CVMR by different methods were made with paired t-tests. Test-retest 
reproducibilities for curvefitting parameters and for CVMR estimation were 
examined by the analysis of typical error (the SD of the differences between the 
two tests divided by square root of 2), which was expressed as a coefficient of 
variation.26 Data are presented as means and SD, and a P < 0.05 was considered 
to be statistically significant. 
 
Results 
Changes in cerebral and systemic hemodynamics. All 10 participants completed 
the experimental protocol, so that 20 data sets were collected. Data from one test 
could not be used because of poor signal quality; hence, reproducibility results 
were available only for nine subjects. Representative changes in CBFV, ABP, 
PETCO2, HR, and MSNA are shown in Fig. 2. Individual values for SaO2 varied 
within the range of 96–100% during baseline breathing of room air and remained 
unchanged during rebreathing, owing to the supplementation of oxygen. There 
was a delayed response of CBFV (mean: 7 s, range 6 –10) and ABP (mean: 14 s, 
range 12–16) to changes in PETCO2 during hyperventilation. Correction for the 
time delay did not significantly alter the result of data analysis. Because the 
physiological validity of applying a time correction for CVMR estimation was 
uncertain, analysis of the raw (uncorrected) data is presented. After the rapid 
return of PETCO2 to the pretest baseline level at the onset of recovery, a 
considerable time delay was observed for the ensuing recovery of CBFV (mean: 
21 s, range 14–35) and of ABP (mean: 22 s, range 12–30). However, this delay 
did not influence the data analysis because the recovery period was not included 
in the models used to assess CVMR in this study. Whereas ABP gradually 
returned to the pretest baseline after rebreathing, CBFV displayed an undershoot 
and then gradually returned to a sustained level, which was below the pretest 
baseline level (mean: 81% of baseline, range 65–90), even at the end of the 4 min 
of recovery. On average, PETCO2 was reduced by 22 Torr during hyperventilation 
and increased by 20 Torr during rebreathing from the pretest baseline (P < 0.001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. A typical recording of baseline, hyperventilation, rebreathing, and recovery in 1 subject. ABP, 
arterial blood pressure; HR, heart rate; MSNA, muscle sympathetic nerve activity. Note the significant 
increases in ABP and MSNA, concurrent with the increase in CBFV during rebreathing. Arrows indicate 
start and end of hyperventilation and rebreathing periods. 
 
These changes in PETCO2 resulted in a respective reduction of CBFV by 46% and 
an increase by 104% relative to the baseline (P<0.001). CVCi fell by 39% during 
hyperventilation and increased by 64% during rebreathing (P < 0.001). Of note, 
ABP was reduced by 19% during hyperventilation and augmented by 23% during 
rebreathing (P<0.01). During rebreathing, increases in ABP appeared to be 
proportional to increases in PETCO2 but leveled off at high levels of PETCO2 (Fig. 2). 
HR increased by 29% during hyperventilation and by 14% during rebreathing 
(P<0.01) (Fig. 2, Table 1). 
 
Table 1. Changes in Cerebral and Systemic Hemodynamics during the Test. 
 
 Baseline Hyperventilation Rebreathing 
Subject PETCO2 CBFV MABP HR PETCO2 CBFV MABP HR PETCO2 CBFV MABP HR 
1 46 60 89 59 23 31 65 76 67 101 101 64 
2 42 82 77 72 22 42 57 87 61 142 92 77 
3 41 89 90 62 24 45 63 70 58 155 142 80 
4 42 45 89 56 16 23 73 68 62 98 101 59 
5 43 71 86 45 17 36 65 79 61 151 103 57 
6 40 56 96 70 13 29 75 94 61 127 108 78 
7 37 60 103 59 20 31 95 73 55 122 123 70 
8 41 41 94 69 21 21 77 81 65 104 108 72 
9 37 55 103 65 23 38 86 85 61 128 139 75 
10 42 62 99 76 22 32 89 97 62 128 119 86 
Mean 41 62 93 63 20* 33* 75* 81* 61* 126* 114* 72* 
SD 3 15 8 9 4 8 12 10 3 20 17 9 
Values are means from all available tests in n=10 subjects.PETCO2: end-tidal CO2 (mmHg). CBFV: cerebral 
blood flow velocity (cm/s). MABP: mean arterial blood pressure (mmHg). HR: heart rate (bpm). Baseline: 
average of 2-minute recordings before hyperventilation. Hyperventilation: lowest values following 15 
seconds of hyperventilation. Rebreathing: average of the last minute of data.  
*:  p < 0.01 for comparison of hyperventilation and rebreathing with baseline.  
 
In the three subjects that underwent recording of MSNA, averaged burst frequency 
increased from 24 at baseline to 30 bursts/min during hyperventilation, and total 
nerve activity increased by 166% (P=0.01). MSNA returned rapidly to baseline 
after cessation of hyperventilation and subsequently increased to 41 bursts/min 
and 446% for total nerve activity during the last minute of rebreathing (P=0.01; Fig. 
2). Changes in MSNA were similar in all three subjects. 
 
Curve-fitting and model parameters. Figure 3 depicts the representative results of 
sigmoidal curve fitting of the CBFV/CVCi-PETCO2 relationship in one subject. The 
specific CVMR derived from the first-order derivative of the logistic function is also 
plotted.  
 
 
 
Fig. 3. Typical data of logistic regression of %changes in CBFV and CVCi to changes in end-tidal 
CO2 (PETCO2) in 1 subject. Sigmoidal curve represents the result of logistic regression; the dotted bell-
shaped curve is the first-order derivative of the identified logistic function. Linear regression was performed 
in the steep portion of the sigmoidal curve to estimate cerebral vasomotor reactivity (CVMR), using CBFV 
and CVCi as the dependent variables, respectively. 
 
The group-averaged data of changes in CBFV and CVCi as well as logistic 
regression of pooled data for all subjects are shown in Fig. 4. Because there were 
no significant differences between results from the first and second tests, all data 
were used in the pooled data analysis. Logistic regression of individual data 
demonstrated an excellent curve-fitting result (mean r2 = 0.95, SD 0.04; average of 
mean sum of squares = 37, SD 19), superior to the use of linear regression (mean 
r2 = 0.88, SD 0.06; average of mean sum of squares = 85, SD 51; P<0.01) for both 
the CBFV-PETCO2 and the CVCi-PETCO2 relationships. Specifically, logistic 
regression was performed well in all 18 tests for changes in CBFV (r2 = 0.97, SD 
0.02) and in 16 of 18 tests for CVCi (r2 = 0.93, SD 0.06). In those two cases of 
CVCi for which logistic regressions could not be performed reliably, linear 
regressions yielded an r2 of 0.71 and 0.76 for CBFV and CVCi, respectively.  
 
 
 
 
Fig. 4. Group (n = 10) averaged results for logistic regression of percent changes in CBFV and CVCi 
to changes in PETCO2. Sigmoidal curve represents the result of logistic regression of pooled group data 
from all subjects (parameters for CBFV: a = 140%, y0 = 198%, x0 = 47 Torr, b = 0.20 Torr -1; parameters for 
CVCi: a = 102%, y0 = 169%, x0 = 47 Torr, b = 0.16 Torr -1; note that these values are similar to the 
parameters obtained by averaging the individual curve fitting results as listed in Table 2). F and error bars, 
Group averages and SDs, respectively, for CBFV (%) and CVCi (%) within 5-Torr ranges of PETCO2 (e.g., 
20–25 25–30, etc.). 
 
Table 2 shows the group-averaged model parameters and the calculated CVMR 
indexes derived, respectively, from the logistic and linear regressions. Over the 
entire range of changes in PETCO2, the linear regression slope of changes in CVCi 
(CVCi-CVMR0) was significantly smaller than that of CBFV (CBFV-CVMR0). The 
steep ranges of the sigmoidal curves were found to lie between 40 and 50 Torr 
PETCO2 for most subjects (Figs. 3 and 4). As expected, in the steep ranges of the 
sigmoidal curves, linear regression slopes of changes in CBFV (CBFV-CVMR1) 
and CVCi (CVCi-CVMR1) were similar to those obtained from the first-order 
derivatives of the identified logistic function (CBFV-CVMRmax and CVCi-
CVMRmax, respectively). Of note, both CVMRmax and CVMR1 were higher than 
the estimates of CVMR from the linear regressions over the entire range of 
changes in PETCO2 (CVMR0). Finally, for test-retest reproducibility, coefficients of 
variation for curve-fitting parameters and for estimates of CVMR are presented in 
Table 2. 
 
 
 
 
 
Table 2.  Estimation of Logistic Function Parameters and CVMR.   
 
 CBFV-PETCO2 CV,% CVCi-PETCO2 CV,% 
 a, %    149 ± 34 17 99 ± 29* 26 
 y0, % 202 ± 35 10 166 ± 30* 11 
 x0, Torr 47 ± 2 6 46 ± 2 4 
 b, Torr-1 0.22 ± 0.06 36 0.28 ± 0.09 58 
 CVMRmax, %/Torr 8 ± 2† 23 6 ± 2† 31 
 CVMR0 , %/Torr 5 ± 1 18 3  ± 1* 18 
 CVMR1, %/Torr 7 ± 1† 9 6 ± 1*† 26 
Values are mean ± SD, from 10 subjects. CV: coefficient of variation. CBFV: cerebral blood flow velocity; a, 
y0, x0, and b, identified logistic function parameters (Fig 1). CVMRmax: maximal cerebral vasomotor 
reactivity (CVMR), peak value of the first-order derivative of the identified logistic function. CVMR0: linear 
regression slope of percentage changes in CBFV over the entire range of changes in PETCO2. CVMR1: 
linear regression slope of CBFV vs. PETCO2 in the steep portion of the sigmoidal curve. 
* p < 0.01 for difference in parameters between CBFV-PETCO2 and CVCi-PETCO2. † p < 0.01 for CVMR0 vs. 
CVMRmax and CVMR1. 
 
Discussion 
We have developed a clinically applicable method to assess CVMR that addresses 
the nonlinear relationship and interactions between transient changes in CO2, 
CBFV, and ABP. Based on a modified rebreathing method, we have observed a 
wide range of breath-by-breath changes in PETCO2 (~20–61 Torr) and 
corresponding changes in CBFV, CVCi, and ABP.  
 The main findings of this study are twofold. First, consistent with our hypothesis, 
transient, breath-by-breath responses of both CBFV and CVCi to changes in 
PETCO2 demonstrate nonlinear properties that can be quantified by a logistic 
function. Second, the magnitude of increases in CBFV during hypercapnic 
rebreathing exceeded CVCi (104% vs. 64%) because of the presence of 
significant increases in ABP by 23%. Consistently, during hypocapnic 
hyperventilation, the reduction in CBFV (46%) surpassed CVCi (39%), whereas 
ABP fell by 19%. These observations suggest that changes in ABP during CO2 
stimuli have direct effects on CBF. 
 
Study limitations. The reproducibility of model parameters and estimates of CVMR 
are comparable with other Doppler-CO2 tests.3,27,28 Nonetheless, the coefficient of 
variation of the model parameter b was relatively large compared with the other 
parameters (Table 2). Parameter b reflects the overall curvilinear properties of the 
sigmoidal curve. Therefore, estimation of parameter b may have been affected by 
the lack of precise control of levels of PETCO2 reached during voluntary 
hyperventilation between the tests. The technique of dynamic end-tidal forcing 
may provide much better control of PETCO2 to improve the reproducibility of model 
parameter’s estimation.29 An additional limitation, inherent to the use of TCD, is 
that CBFV was measured to reflect changes in CBF. The TCD method has been 
well validated against other modalities used to measure CBF.30-32 However, 
changes in CBFV reflect changes in CBF only if the diameter of the insonated 
MCA remains constant. Direct and indirect measurements of the MCA diameters 
and comparisons of changes in CBFV with changes in CBF measured by different 
modalities during either hypo- or hypercapnia suggest the validity of using 
TCD.33,34 We cannot exclude the possibility that a vasodilatation in the MCA may 
occur at high levels of CO2.35 If this were the case, the magnitude of maximal 
changes in CBF may have been underestimated by the measurement of CBFV 
during hypercapnia. However, the maximum changes in CBFV at a PETCO2 level of 
60 Torr (~100% above baseline) are consistent with results of direct 
measurements of CBF in other studies with a similar level of changes in CO2.2,7 
Magnitude of changes in CBFV and ABP. We found marked changes in CBFV with 
a range of nearly 150% from hyperventilation to rebreathing, with rebreathing 
accounting for an estimated doubling of baseline CBF. This range of changes in 
CBF is comparable with those found in other studies using TCD or other 
techniques to measure CBF.2,7,19,29,36,37 Prominent CBF responses to arterial CO2 
are well established.2-4,12 These changes in CBF have been attributed mainly to 
cerebral vasodilatation during hypercapnia and vasoconstriction during 
hypocapnia.38,39 
 However, changes in arterial CO2 elicit complicated autonomic reflexes and 
exert vascular effects not only in the cerebral but also in the systemic 
circulation.40,41 ABP increases substantially even during moderate increases in 
arterial CO2, due largely to sympathetic activation5,10,42,43, which clearly occurred in 
our study as well. This chemoreflexmediated sympathetic activation may have 
confounding and opposing effects for the cerebral circulation, especially in the 
setting of CO2-induced cerebral vasodilatation. For example, systemic 
hypertension may increase CBF prominently when normal autoregulatory 
mechanisms are impaired by CO2.6,8,44 Conversely, sympathetic activation in the 
brain may restrain CO2-induced vasodilatation39,45-47, although it is less certain 
whether such effects occur consistently in humans.48 Both of these opposing 
effects will influence the measurement of CVMR during rebreathing.  
 In the present study, we found that estimates of CVMR based on CBFV (during 
either hyper- or hypocapnia) exceeded those based on CVCi. For example, model 
parameters a and y0 (which reflect the range and maximal changes in CBFV and 
CVCi, respectively) derived from the CBFV-PETCO2 relationship were significantly 
higher than those obtained from the CVCi-PETCO2 relationship. Likewise, linear 
regressions resulted in higher values for CVMR when derived from CBFV instead 
of CVCi.  
 According to Ohm’s law, the much higher increases in CBFV (104%) during 
hypercapnia relative to the increases in CVCi (64%) could be attributed to the 23% 
increase in ABP. Consequently, increases in ABP led to an overestimation of 
CVMR based on the linear regression of changes in CBFV vs. PETCO2 (CBFV-
CVMR0) (Table 2).6 Together, these findings suggest that the net CBF responses 
to acute hypercapnia in humans are dominated by an overwhelming vasodilatory 
effect of CO2, which impairs cerebral autoregulation and thereby enhances the 
effects of ABP on CBFV. 
 
Estimation of CVCi. This study applies changes in cerebrovascular conductance to 
assess CVMR during transient changes in PETCO2. The use of CVCi, in contrast to 
changes in CBFV, may better reflect the physiological process of cerebral 
vasodilatation during hypercapnia and cerebral vasoconstriction during 
hypocapnia. When an index of cerebrovascular resistance (the inverse of 
conductance) is used rather than CBFV to assess CVMR, the outcome was less 
influenced by changes in ABP.6 However, the use of resistance, rather then its 
inverse conductance, to assess CVMR may lead to difficulties in data 
interpretation, especially under conditions with increased CBF.49 Because of their 
reciprocal relationship, in a condition where resistance is low and blood flow is 
high, a large increase in conductance (vasodilatation) leads to only a small 
(further) decrease in resistance. Therefore, if vasomotor responses are estimated 
from changes in resistance, such a small decrease in resistance could be falsely 
interpreted to represent a small increase in vasodilatation. Because CVMR testing 
generates high blood flow, conductance rather than resistance was used in this 
study.  
 Alternatively, studies have analyzed the ABP-CBFV relationship within each 
cardiac cycle and used linear extrapolations to calculate the zero-flow pressure 
(also known as critical closing pressure) or resistance-area product indexes.24,50,51 
Hypocapnia increases and hypercapnia reduces zero-flow pressure; therefore, 
changes in these indexes may serve as alternative measures to assess 
cerebrovascular responses to CO2.23,24 Whereas the clinical relevance of 
assessment of CVMR has been demonstrated in follow-up studies in patients at 
risk for cerebrovascular events14,15, similar findings have not been reported for 
zero-flow pressure or resistance-area product parameters. 
 
Temporal characteristics of changes in CBFV and ABP. The CBF response to 
transient changes in CO2 has a time delay of ~5–7 s.9,52 It is therefore of interest to 
consider whether this factor could affect the estimation of CVMR using the 
proposed modeling. Identification of the time delay between transient changes in 
CBF and PETCO2, as performed in these studies, requires complex and stringent 
control of respiration and CO2 levels. However, in the present study, we are able to 
approximate the time delay between changes in PETCO2, CBFV, and ABP based 
on the individual data from each subject. The average time delay of the reduction 
in CBFV in response to the reduction in PETCO2 during hyperventilation was ~7 s, 
consistent with the reported time delay after a negative step change in PETCO2 (6.8 
s) 52 and with a time delay of ~5 s found when spontaneous CO2 oscillations were 
analyzed.11 This time delay is possibly explained by CO2 transportation time.53 The 
identification of a similar time delay during hypercapnic rebreathing is less evident 
because, as can be seen in Fig. 2, rebreathing caused a ramplike increase in 
PETCO2. Despite the time delay between transient changes in CBFV and CO2, it 
had little effect on the estimation of CVMR. With a total duration of hyperventilation 
of 15 s, a (short) plateau phase with minimum and stable CO2 and CBFV values 
was reached in all individuals. Values at the end of hyperventilation (i.e., in this 
plateau phase) were used as a starting point for calculation of CVMR. Therefore, 
“correction” for the time delay did not affect the modeling and data outcome. 
Similarly, the observed reduction in ABP during hyperventilation also showed a 
time delay, lagging behind the changes in CBFV by an additional 7 s. This delayed 
response in ABP may partly explain why there was a smaller difference between 
changes in CVCi and CBFV during hyperventilation when compared with 
hypercapnic rebreathing. 
 During rebreathing, CBFV increased steadily, associated with a continuous 
increase in PETCO2, and then appeared to level off at high levels of PETCO2. Two 
mechanisms may have contributed to the saturation of CBFV. First, cerebral 
vasodilatation may have reached its maximal levels at or greater than a PETCO2 of 
60 Torr.3,12 Second, substantial sympathetic activation may constrain the 
magnitude of the CBFV responses.39,45,48 
 With the onset of recovery, PETCO2 returned rapidly to the pretest baseline level 
within ~1–2 breaths of room air (<10 s). However, there was a substantial time 
delay of ~20 s for CBFV to reach a new sustained level, which was lower than the 
pretest baseline value. Of note, ABP returned to the pretest baseline level without 
a similar undershoot. These data suggest a sustained cerebral vasoconstriction 
during recovery from prolonged acute hypercapnia. In addition, these data confirm 
that adaptive processes modify the response in both ABP and CBF to CO2, 
leading to limitations in the use of steady-state data to estimate CVMR.7,52 
However, the time delay in the recovery of CBFV appears to be much longer than 
that reported with a step change in CO2 (6 s).29 These discrepancies might be 
related to the differences in the duration as well as the intensities of CO2 stimuli 
used. 
 
Assessment of CVMR. A sigmoidal distribution of data was present in most 
subjects when breath-by-breath changes in CBFV were plotted against PETCO2. 
Furthermore, similar distributions were observed for changes in CVCi, indicating 
the presence of threshold and saturation properties of cerebrovascular changes in 
response to transient changes in PETCO2, providing further evidence for the 
nonlinear properties of CBF responses to changes in CO2.3,12,29,52,53 However, the 
specific physiological mechanisms underlying the nonlinear CBF-CO2 relationship 
cannot be determined in the present study. 
 Data with a sigmoidal distribution could be fitted equally well with several 
nonlinear functions based on the norm of least-square curve-fitting procedures.12 A 
modified logistic function was employed for curve fitting.25 Compared with other 
curve-fitting methods, one advantage of the logistic function used in this study is 
that the model parameters identified have clear physiological meanings (Fig. 1). In 
addition, the first-order derivative of the identified logistic function readily provides 
an estimation of CVMR for each level of PETCO2. 
 The linear regression slope of the CBFV-PETCO2 relationship (CVMR0, 5%/Torr) 
over the entire range of changes in PETCO2 is consistent with previous findings. 
2,7,29,54 However, this method of analysis, although practical, evidently 
underestimates the maximal cerebral vasodilatory effect of CO2, as indicated by 
the estimates of CVMRmax using either the first-order derivatives of the identified 
logistic function (8%/Torr) or the specific linear regressions in the steep portion of 
sigmoidal curves (7%/Torr) (Table 2). 
 The inflection point of the logistic function (parameter x0), which corresponds to 
the maximal rate of changes in CBFV or CVCi to CO2 (CVMRmax), was almost 
identical for both the CBFV-PETCO2 and CVCi-PETCO2 relationships (Table 2). This 
demonstrates that CVMRmax occurs during moderate hypercapnia, slightly above 
the baseline level of PETCO2, consistent with previous studies suggesting that 
estimation of CVMR is lower during hypocapnia than during hypercapnia.6,19,29,36 
 Previous studies have used similar rebreathing methods to estimate CVMR. 
19,37,54,55 However, these studies investigated only the hypercapnic stimuli and 
used linear regressions to derive a CVMR from 2.8 to 5.2%/Torr.37,54,55 Only one 
study included the hypocapnic range using hyperventilation before rebreathing and 
applied a bilinear model, resulting in a smaller CVMR in the hypocapnic range 
than in the hypercapnic range (1.6 vs. 2.8 cm·s -1·Torr -1).19 Direct comparisons to 
these previous findings are difficult because hypoxic and/or hyperoxic conditions 
were also employed in these studies. 
 In conclusion, a clinically applicable rebreathing method was developed to 
assess CVMR during transient changes in PETCO2. We found that both CBFV and 
CVCi responses to transient changes in PETCO2 are nonlinear and that these 
responses can be quantified well by a modified logistic function. Furthermore, we 
found that the magnitude of change in CBFV during CO2 rebreathing (and 
hyperventilation) is higher than that of CVCi, suggesting direct effects of increases 
(and decreases) in ABP on changes in CBFV. For assessment of CVMR, the 
range of changes in CO2 to be studied and the confounding influence of changes 
in ABP on CBFV must be considered for application of an appropriate modeling 
method to quantify CBFV or CVCi responses. 
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